Table 3.
Placebo (n = 51) | Probiotics (n = 45) | P-value | |
---|---|---|---|
Intraoperative blood loss (ml) | 100 (50,200) | 100 (50,200) | 0.06 |
Total intra-operative infusion (ml) | 1,200 (1,100, 1,700) | 1,300 (1,050,1,700) | 0.69 |
Dexmedetomidine | 15 | 12 | 0.77 |
Type of anesthesia | 0.36 | ||
intravertebral | 27 (52.9) | 28 (62.2) | |
General | 24 (47.1) | 17 (37.8) | |
Length of operation (h) | 120.0 (110.0,155.0) | 125.00 (95.0,145.0) | 0.74 |
Intra-operative antibiotic | 1 | ||
β-lactam | 47 (92.2%) | 42 (93.3%) | |
Quinolones | 1 (1.1%) | 1 (0.9%) | |
Polypeptide | 3 (2.7%) | 2 (2.3%) | |
Postoperative antibiotic | 0.87 | ||
β-lactam | 47 (92.2%) | 40 (88.9%) | |
Quinolones | 1 (2.0%) | 2 (4.4%) | |
Polypeptide | 3 (5.9%) | 3 (6.7%) | |
Postoperative analgesia regime | 0.21 | ||
Sufentanil | 30 (58.8%) | 32 (71.1%) | |
Sufentanil and dezocine | 21 (41.2) | 13 (28.9%) |
All data are presented as number (%), median (first quartile, third quartile), or mean ± SD.